Vinnova

BeammWave AB is a Swedish company based in Lund that specializes in the manufacture of radio frequency integrated chips, specifically designed for digital beamforming applications. Founded in 2016, BeammWave develops a single chip that integrates front-end components and antenna arrays, catering to mobile phones and Internet of Things (IoT) devices. The company's technology operates in the millimeter-wave spectrum, supporting 5G and future wireless communication standards. Through its innovative solutions, BeammWave aims to enhance connectivity and performance in modern communication devices.

Saab Ventures, established in 2001, is the corporate venture capital arm of Saab AB, headquartered in Stockholm, Sweden. It invests in technology companies, with a focus on those rooted in the defense, civil security, aviation, and space sectors. The firm makes both direct investments in startups and early-stage companies, as well as fund-of-fund investments in venture capital funds. Saab Ventures typically invests between SEK0.1 million and SEK50 million, seeking companies with an enterprise value between SEK40 million and SEK100 million within five years, and existing or potential revenues of SEK100 million within the same period. It prefers minority equity positions and co-investment opportunities, with an investment horizon of four to seven years.

XNK Therapeutics is a clinical-stage biotechnology company based in Stockholm, Sweden, specializing in immunotherapy for cancer prevention and treatment. The company is focused on developing innovative autologous natural killer (NK) cell-based therapies using its proprietary technology platform. XNK Therapeutics has positioned itself as a leader in the clinical development and manufacture of these therapies, which are designed to effectively target cancers, particularly in scenarios where allogeneic cell products may not be suitable. By harnessing the unique properties of its investigational drug candidates, XNK Therapeutics aims to play a crucial role in advancing cancer treatment strategies.

Qlucore is a prominent provider of advanced bioinformatics software designed for research and precision diagnostics in the life sciences. Founded in 2007 by researchers from Lund University in Sweden, the company aims to simplify the analysis of complex data generated in the fields of genetics and proteomics. Its flagship product, Qlucore Omics Explorer, is a user-friendly bioinformatics tool that enables researchers, technicians, and physicians to easily interpret and visualize large datasets. Additionally, Qlucore offers Qlucore Diagnostics, an AI-powered platform for multi-omics companion and precision diagnostics that integrates with various data-generating instruments. With a global presence, Qlucore serves customers in approximately 35 countries, including leading pharmaceutical companies, hospitals, and academic institutions.

Intervacc is a biotechnology company that specializes in the development of vaccines utilizing recombinant proteins for animal health care. The company addresses the growing demand for effective vaccines by creating innovative solutions tailored to this sector. In addition to its vaccine development, Intervacc, through its subsidiary, is engaged in diagnostics within the Swedish animal health market, providing comprehensive bacteriological and mycological analyses. Through these efforts, Intervacc aims to enhance animal health and contribute to the overall well-being of veterinary care.

Mycorena AB, founded in 2017 and based in Gothenburg, Sweden, specializes in the development of nutritious fungi-based protein. The company aims to provide a sustainable alternative to both meat and traditional plant-based proteins, leveraging fungi biotechnology to create vegan protein solutions that use significantly fewer resources. Mycorena addresses global sustainability challenges by promoting a circular economy through its innovative food manufacturing processes. Its products enable customers to make environmentally conscious choices while contributing to a more sustainable food system.

InDex Pharmaceuticals AB, founded in 2016 and based in Stockholm, Sweden, is a clinical-stage biopharmaceutical company focused on developing innovative treatments for immunological diseases. Its flagship product, cobitolimod, is designed to provide local anti-inflammatory effects, healing mucosa and improving clinical symptoms in patients with ulcerative colitis. The company's platform technology involves DNA-based ImmunoModulatory Sequences (DIMS), which are used to treat a variety of immunological diseases. Additionally, InDex Pharmaceuticals offers DiBiCol, a diagnostic kit that monitors biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy.

Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.

Jaisy Health is a company based in Stockholm, Sweden, that specializes in developing jaundice detection equipment aimed at providing a low-cost and highly accurate solution for non-invasive jaundice assessment in infants. Founded in 2018, Jaisy Health utilizes advanced technology to create an optical mobile device that connects to smartphones. This device measures bilirubin levels and predicts the risk of jaundice, enabling timely and accessible detection regardless of location or time. By focusing on affordability and accuracy, Jaisy Health offers an innovative approach to managing jaundice in newborns.

Redsense Medical AB, founded in 2000 and headquartered in Halmstad, Sweden, specializes in developing and marketing safety systems for medical treatments, primarily focusing on the dialysis sector in Europe and the United States. The company's flagship product, the Redsense System, utilizes patented fiber optic sensors to detect blood leakage during hemodialysis, triggering visual and audible alarms to alert caregivers and patients. In addition to the alarm system, Redsense Medical is developing the Redsense Clamp, an accessory designed to automatically stop blood flow by clamping the blood line upon detection of an issue. With a commitment to enhancing patient safety, the company provides innovative solutions tailored to the needs of healthcare providers in the dialysis industry.

Mendi is a company based in Stockholm, Sweden, that specializes in developing an at-home neurofeedback brain training headband and accompanying mobile application. Founded in 2018, Mendi's innovative hardware device aims to enhance mental well-being by improving focus, emotional regulation, and mental resilience. The headband can be used in conjunction with the app to facilitate mental training, allowing users to engage in brain-strengthening exercises with no usage limits. Through this technology, Mendi seeks to empower individuals to enhance their overall mental health and performance.

Yolean AB is a Swedish company based in Gothenburg that specializes in developing visual management tools aimed at facilitating digital Lean transformations. The company provides software solutions that integrate wall-based visual management techniques with backend data management, allowing project and knowledge managers to enhance visibility and transparency in knowledge work. Yolean's offerings include visual planning tools, pulse solutions, and check sheets, which support real-time collaboration across teams and help identify bottlenecks in workflow. By serving clients in sectors such as automotive and public services, Yolean focuses on improving team synchronization and project management through effective visual collaboration and continuous data-driven improvements.

TrusTrace is a software company based in Stockholm, Sweden, with an additional location in Coimbatore, India, that specializes in traceability as a service for the fashion supply chain. Founded in 2016, TrusTrace offers a comprehensive platform that enables global brands and suppliers to capture, digitize, and share supply chain and material traceability data efficiently. Its suite of tools includes T-Tracem for end-to-end product traceability, T-CET for customer engagement, I-CAT for climate action management, and T-VeM for vendor management, among others. The platform consolidates validated supply chain data, allowing brands to substantiate product claims and ensure regulatory compliance while managing their environmental impact. By providing a single platform for traceability, TrusTrace empowers brands to enhance transparency and trust in their supply chains.

Grönska is a young, Swedish tech-company that develops technology for vertical farming, and grows and sells vegetables and herbs. Vertical farming that is based on the use of LED lighting and hydroponic watering systems. This method allows us to grow food indoors, locally and all year round. The reason we do this is to offer a sustainable, locally grown alternative to imported food and to enable more self-sufficient cities. Grönska was founded in 2014 and constructed the largest vertical farm in the Nordics in 2018.

Bintel AB is a Swedish company founded in 2018 and based in Helsingborg that specializes in developing and marketing innovative sensors for waste management. Its primary product is a digital waste-management platform that includes sensors mounted on household waste bins. These sensors notify waste collectors when bins are full and communicate with route planning tools to optimize collection routes. This technology is designed to assist recycling companies, real estate firms, and municipalities in reducing waste collection costs and improving overall efficiency in waste management.

DeviceRadio AB is a Swedish company based in Malmö, founded in 2016, that focuses on creating a communication layer designed to facilitate data transfer across various devices and connectivity methods in the Internet of Things (IoT) sector. The company's innovative solution allows seamless communication between devices using different technologies, including Bluetooth, broadband cellular networks, WiFi, and SMS. By addressing the complexity and fragmentation in the IoT landscape, DeviceRadio aims to provide a unified infrastructure that enables developers to integrate and utilize IoT capabilities more effectively. This approach not only enhances operational efficiency but also supports the development of diverse applications, such as improving emergency response times and agricultural productivity, thereby contributing to a more connected and efficient future.

Spago Nanomedical AB is a Swedish company focused on developing innovative nanomaterials for cancer diagnostics and treatment. Founded in 2007 and based in Lund, the company offers two key products: SpagoPix and Tumorad. SpagoPix is a tumor-selective contrast agent designed to enhance cancer diagnosis through improved magnetic resonance imaging, enabling the early detection of tumors and metastases. Tumorad, on the other hand, represents a novel approach to radionuclide therapy, delivering targeted radiation directly to tumor tissue. The company’s research and development efforts are grounded in a platform of polymeric materials, which possess various properties aimed at providing precise solutions for the diagnosis and treatment of serious medical conditions, particularly cancer. Spago Nanomedical was previously known as Spago Imaging AB until its name change in May 2014.

Imagimob AB is a Stockholm-based company specializing in artificial intelligence products focused on movement analytics for both objects and people. The company has developed SensorBeat, a comprehensive motion intelligence system that integrates hardware and software components, including sensors, storage, Bluetooth low energy capabilities, and communication ports. SensorBeat is designed for real-time artificial intelligence processing at the edge, allowing for applications such as audio classification, gesture recognition, predictive maintenance, fall detection, and material detection. This platform enables companies to efficiently create and deploy AI applications for embedded devices, enhancing their functionality and responsiveness.

TrusTrace is a software company based in Stockholm, Sweden, with an additional location in Coimbatore, India, that specializes in traceability as a service for the fashion supply chain. Founded in 2016, TrusTrace offers a comprehensive platform that enables global brands and suppliers to capture, digitize, and share supply chain and material traceability data efficiently. Its suite of tools includes T-Tracem for end-to-end product traceability, T-CET for customer engagement, I-CAT for climate action management, and T-VeM for vendor management, among others. The platform consolidates validated supply chain data, allowing brands to substantiate product claims and ensure regulatory compliance while managing their environmental impact. By providing a single platform for traceability, TrusTrace empowers brands to enhance transparency and trust in their supply chains.

DeviceRadio AB is a Swedish company based in Malmö, founded in 2016, that focuses on creating a communication layer designed to facilitate data transfer across various devices and connectivity methods in the Internet of Things (IoT) sector. The company's innovative solution allows seamless communication between devices using different technologies, including Bluetooth, broadband cellular networks, WiFi, and SMS. By addressing the complexity and fragmentation in the IoT landscape, DeviceRadio aims to provide a unified infrastructure that enables developers to integrate and utilize IoT capabilities more effectively. This approach not only enhances operational efficiency but also supports the development of diverse applications, such as improving emergency response times and agricultural productivity, thereby contributing to a more connected and efficient future.

Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.

Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

InDex Pharmaceuticals AB, founded in 2016 and based in Stockholm, Sweden, is a clinical-stage biopharmaceutical company focused on developing innovative treatments for immunological diseases. Its flagship product, cobitolimod, is designed to provide local anti-inflammatory effects, healing mucosa and improving clinical symptoms in patients with ulcerative colitis. The company's platform technology involves DNA-based ImmunoModulatory Sequences (DIMS), which are used to treat a variety of immunological diseases. Additionally, InDex Pharmaceuticals offers DiBiCol, a diagnostic kit that monitors biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy.

Fundler AB, established in Stockholm, Sweden in 2015, operates an automated investment platform for private investors. The company, previously known as Primepilot AB, offers a robo-advisory service that tailors portfolios of funds and exchange-traded funds based on clients' investment horizons, financial situations, risk profiles, goals, knowledge, and experience. Through its app, Fundler enables users to place orders for purchases or sales, facilitating the management of their savings portfolios automatically.

Bokio AB, founded in 2015 and based in Gothenburg, Sweden, specializes in developing and marketing accounting software that leverages artificial intelligence. The company provides solutions for bookkeeping, invoicing, and payroll services, making accounting accessible to small business owners, particularly in the UK. Its platform automates various financial processes, allowing users to efficiently manage their finances in one place. Additionally, Bokio serves as a marketplace for supplementary services that assist small business owners in simplifying their operations, including finding optimal insurance and pension solutions. The company also collaborates with partners to offer services like invoice sales to enhance liquidity and facilitates the sending of payslips and invoices through conventional mail, encompassing printing, envelopes, and postage.

VBN Components AB is a Swedish manufacturer specializing in 3D printed metal parts using its proprietary Vibenite® alloys. These parts are renowned for their exceptional wear and heat resistance, making them ideal for industrial applications. The company's patented free molding technology allows for the creation of complex, free-form components with reduced material waste and faster production times, eliminating the need for traditional metal cutting processes. VBN Components' innovative approach enables manufacturers to enhance the performance of their end products through improved geometry and increased wear resistance.